THE HISTORICAL AND EPIDEMIOLOGICAL ASPECTS AND RISK FACTORS OF PREMENSTRUAL SYNDROME


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Premenstrual syndrome (PMS) is a common abnormality characterized by diverse cyclically recurrent symptoms that develop during the luteal phase of the menstrual cycle. The rate of PMS depends on age: PMS is observed in 20% of women at the age of 19-29 years, the syndrome is encountered in nearly every two women after 30 years of age, and its incidence is more than 55% among women over 40 years of age. Recent investigations have established that young girls have a much higher prevalence of PMS (its rate may be as high as 70% or more). The review gives data on the most common manifestations of PMS and basic theories of its occurrence and considers the historical and epidemiological aspects of this pathological condition.

Full Text

Restricted Access

About the authors

A. V LEDINA

Russian Medical Academy of Postgraduate Education, Ministry of Health and Social Development of Russia

V. G AKIMKIN

I.M. Sechenov First Moscow State University; Research Institute of Disinfectology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Email: vgakimkin@yandex.ru

V. N PRILEPSKAYA

Russian Medical Academy of Postgraduate Education, Ministry of Health and Social Development of Russia

References

  1. Johnson S.R. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet. Gynecol. 2004; 104: 845-859.
  2. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder - clinical procedures and research perspectives. Gynecol. Endocrinol. 2004; 19: 320-334.
  3. Mustaniemi S., Sipola-Leppänen M., Hovi P. et al. Premenstrual symptoms in young adults born preterm at very low birth weight - from the Helsinki Study of Very Low Birth Weight Adults. BMC Womens Health. 2011; 3: 11-25.
  4. Hylan T.R., Sundell K., Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: Experience from United States, United Kingdom and France. J. of Women’s Health & Gender-Based Medicine 1999; 8: 1043-1052.
  5. Sveinsdottir H., Backstrom T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet. Gynecol. Scand. 2000; 79: 405-413.
  6. Wittchen H. U., Becker E., Lieb R. et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol. Med. 2002; 32: 119-132.
  7. Deuster P.A., Adera T., South-Paul J. Biological, Social, and Behavioral Factors Associated With Premenstrual Syndrome. Arch. Fam. Med. 1999; 8: 122-128.
  8. Гржибовский А.М. Использование статистики в российской биомедицинской литературе. Экология человека 2008; 12: 55-64.
  9. Mishell D.R.Jr. Premenstrual Disorders: Epidemiology and Disease Burden. Am. J. Manag. Care. 2005; 16(11): S473-S479.
  10. Tschudin S., Bertea P.C., Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch. Womens Ment. Health 2010; 13(6): 485-494.
  11. Connolly M. Premenstrual syndrome: on update on definitions, diagnosis and management. Advances in Psychiatric Treatment 2001; 7: 469-477.
  12. Silva C.M., Gigante D.P., Carret M.L. et al. Population study of premenstrual syndrome. Rev. Saude Publica 2006; 40(1): 47-56.
  13. Angst J., Sellaro R., Merikangas K.R. et al. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr. Scand. 2001; 104(2): 110-116.
  14. Кулаков В.И., Серов В.Н., Жаров Е.В. Гормональная контрацепция и здоровье женщины. М.: ORGYN, 2006.
  15. Прилепская В.Н., Межевитинова Е.А. Предменструальный синдром. Гинекология 2005; 7(4): 210-214.
  16. Савельева Г.М., Бреусенко В.Г. Гинекология. М.: ГЭОТАР-Медиа, 2004: 83-87.
  17. Серов В.Н., Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокринология. М.: МЕДпресс-информ, 2004: 209-235.
  18. Кузнецова М.Н. Предменструальный синдром и его лечение. Акуш. и гин. 1973; 5: 55-59.
  19. Nisar N., Zehra N., Haider G. et al. Frequency, intensity and impact of premenstrual syndrome in medical students. J. Coll Physicians. Surg. Pak. 2008; 18(8): 481-484.
  20. Pinar G., Colak M., Oksuz E. Premenstrual Syndrome in Turkish college students and its effects on life quality. Sex Reprod. Health 2011; 2(1): 21-27.
  21. Wong L.P., Khoo E.M. Menstrual-Related Attitudes and Symptoms Among Multi-racial Asian Adolescent Females. Int. J. Behav. Med. 2010; 16(2): S19- S22.
  22. Adewuya A.O., Loto O.M., Adewumi T.A. Premenstrual dysphoric disorder amongst Nigerian university students: Prevalence, comorbid conditions, and correlates. Arch. Womens Ment. Health 2008; 11: 13-18.
  23. Sternfeld B., Swindle R., Chawla A. et al. Severity of premenstrual symptoms in a health maintenance organization population. Obstet. Gynecol. 2002; 99: 10141024.
  24. Rojnich Kuzman M., Hotujac L. Premenstrual dysphoric disorder - a neglected diagnosis? Preliminary study on a sample of Croatian students. Coll. Antropol. 2007; 31(1): 131-137.
  25. Tabassum S., Afridi B., Aman Z. et al. Premenstrual syndrome: Frequency and severity in young college girls. J. Pak. Med. Assoc. 2005; 55: 546-549.
  26. Issa B.A., Yussuf A.D., Olatinwo A.W. et al. Premenstrual dysphoric disorder among medical students of a Nigerian university. Ann. Afr. Med. 2010; 9(3): 118-122.
  27. Линде В.А., Аганезова Н.В., Корчагина З.В. и др. Психодиагностика в комплексном обследовании женщин с предменструальным синдромом. В кн.: Психоневрология в современном мире. Материалы юбилейной научной сессии. СПб, 2007: 216.
  28. Freeman E.W., Sondheimer S.J. Premenstrual dysphoric disorder: recognition and treatment. Primary Care Companion. J. Clin. Psychiatry 2003; 5: 30-39.
  29. Pearlstein T., Steiner M. Premenstrual dysphoric disorder: Burden of illness and treatment update. J. Psychiatry Neurosci. 2008; 33: 291-301.
  30. Schatzberg A.F., Nemeroff C.B. Textbook of Psychopharmacology. Arlington. American Psychiatric Publishing, 2004.
  31. Stein D.J., Kupfer D.J., Schatzberg A.F. Textbook of Mood Disorders. Arlington. American Psychiatric Publishing, 2005. 352 р.
  32. Zukov I., Ptacek R., Raboch J. et al. Premenstrual dysphoric disorder-review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy. Prague Medical Report. 2010; 111(1): 12-24.
  33. Upshur J.N. The disorders of menstruation. A practical treatise. New York-London: G.P. Putnam’s sons, 1986. 311 р.
  34. Руководство к практическим занятиям по гинекологии / Под ред. В.Е. Радзинского. М.: МИА, 2005: 142-149.
  35. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 2003; 28: 55-99.
  36. Hutchinson S.L., Silberstein S.D. Menstrual migraine: case studies ofwomen with estrogen-related headaches. Headache 2008; 48(3): 131-141.
  37. Seippel L., Bäckström T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 1998; 83(6): 1988-1992.
  38. Ford O., Lethaby A., Roberts H. et al. Progesterone for premenstrual syndrome. Cochrane Database Syst. Rev. 2009; 2: CD003415.
  39. Ying Y.K., Soto-Albors C.E., Randolph J.F. et al. Luteal phase defect and premenstrual syndrome in an infertile population. Obstet. Gynecol. 1987; 69(1): 96—98.
  40. Тарасова М.А., Лекарева Т.М., Потин В.В. и др. Предменструальный синдром. СПб.: Н—Л., 2007. 50 с.
  41. Brown J., O’ Brien P.M., Marjoribanks J. et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst. Rev. 2009; 2: CD001396.
  42. Попова А.К., Куликов А.В. Многообразие серотонинергических рецепторов как основа полифункциональности серотонина. Успехи функциональной нейрохимии: Сборник статей. СПб, 2003: 56—73.
  43. Mah P.M., Webster J. Hyperprolactinemia: etiology, diagnosis and management. Semin. Reprod. Med. 2002; 20(4): 365 —374.
  44. Milewicz A., Jedrzejuk D. Premenstrual syndrome: From etiology to treatment. Maturitas 2006; 55(1): 47—55.
  45. Bertone-Johnson E.R., Chocano-Bedoya P.O. Dietary vitamin D intake, 25-hydroxyvitamin D(3) levels and premenstrual syndrome in a college-aged population. J. Steroid. Biochem. Mol. Biol. 2010; 121(1—2): 434—437.
  46. Whelan A.M., Jurgens T.M., Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can. J. Clin. Pharmacol. 2009; 16(3): 407—429.
  47. Itsekson A., Lazarov A., Cordoba M. et al. Premenstrual syndrome and associated skin diseases related to hypersensitivity to female sex hormones. J. Reprod. Med. 2004; 49(3): 195—199.
  48. Аганезова Н.В., Морозова Е.Б., Чухловин А.Б. и др. Связь симптоматики предменструального синдрома с функциональным полиморфизмом патогенетически значимых генов. Журн. акушерства и женских болезней 2007; LVI(2): 10—18.
  49. Татарчук Т.Ф., Венцковская И.Б., Шевчук Т.В. и др. Предменструальный синдром. Эндокринная гинекология (клинические очерки) / Под ред. Т.Ф. Татарчука, Я.П. Сольского. Киев: Заповит, 2003. 11 c.
  50. Balaha M.H., Abd El Monem Amr M., Saleh Al Moghannum M. et al. The phenomenology of premenstrual syndrome in female medical students: a cross sectional study. Pan. Afr. Med. J. 2010; 5: 4.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media